Turning point in drug prices is around the corner, says Cantor Fitzgerald's Louise Chen
Louise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug ...
Cantor Fitzgerald’s Howard Lutnick breaks into interest-rate futures market to challenge behemoth CME
Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into ...
Fintel on MSN3d
Cantor Fitzgerald Downgrades 4D Molecular Therapeutics (FDMT)
Fintel reports that on September 23, 2024, Cantor Fitzgerald downgraded their outlook for 4D Molecular Therapeutics (NasdaqGS ...
Snap Inc. (SNAP): Among Cantor Fitzgerald’s Top Internet Stock Picks
We recently compiled a list of Cantor Fitzgerald’s Top Internet Stocks: Best Stocks To Buy According To $13.2 Billion Firm.
Cantor Fitzgerald Remains a Buy on Vera Therapeutics (VERA)
Cantor Fitzgerald analyst Pete Stavropoulos maintained a Buy rating on Vera Therapeutics (VERA – Research Report) yesterday and set a ...
Novo Nordisk, Lilly weight loss drugs poised for price reductions: Cantor's Louise Chen
Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...
The New York Times10d
Cantor Fitzgerald LP
Now a $54 billion investment firm is in the mix. By Matthew Goldstein For a Cantor Fitzgerald lawyer, a summer ritual in Central Park is a reminder of how New York can heal the hurting.
Cantor Fitzgerald Keeps Their Buy Rating on Nano-X Imaging (NNOX)
In a report released on September 20, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Nano-X Imaging (NNOX – Research ...